Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q: What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2026?

2 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 221015100

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 120
Total 13F value: $1,792
Share change: +92
SEC-reported price per share: $14.93
Number of holders: 2
Value change: +$1,374
Number of buys: 1
Shares outstanding: 91,091,040

Security key

221015100

Report period

Q2 2026

Institutions

Top holders

CRVS full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Corvus Pharmaceuticals, Inc. SEC filings Corvus Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 221015100

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

15/15

Latest evidence

31 Mar 2026

13F 13D/G 3/4/5 Lead comparable stake: 10% 13D/G row: ORBIMED ADVISORS LLC Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 5

ORBIMED ADVISORS LLC 10%

Richard A. Miller MD 7.8%

Sirenia Capital Management LP 7.5%

BlackRock, Inc. 6.4%

ADAMS STREET PARTNERS LLC 3.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F 13D/G 3/4/5 Company · Director, 10%+ Owner 13F 13D/G 3/4/5	10% from 13D/G	$104,824,038 7,165,006 shares	—	31 Mar 2026
Richard A. Miller MD	13D/G 3/4/5 Richard A. Miller · President and CEO, Director 13D/G 3/4/5	7.8%	$40,653,959 6,085,922 shares	+$5,781,901	31 Dec 2025
Sirenia Capital Management LP	13D/G 13D/G	7.5%	$101,657,601 6,831,828 shares	$0	31 Mar 2026
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	6.4% from 13D/G	$90,126,972 6,160,422 shares	—	31 Mar 2026
ADAMS STREET PARTNERS LLC	13F 13D/G 3/4/5 Company · 10%+ Owner 13F 13D/G 3/4/5	3.9% from 13D/G	$47,922,262 3,275,616 shares	—	31 Mar 2026
STATE STREET CORP	13F Company 13F	3.9%	$52,170,463 3,565,992 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

120

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

164

Q2 2026 holders

Holder diff

-162

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend